XML 43 R33.htm IDEA: XBRL DOCUMENT v3.24.3
Derivative Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
The following table reflects the fair value amounts for designated and non-designated hedging instruments at September 30, 2024 and December 31, 2023 (in thousands):
September 30, 2024December 31, 2023
Fair Value
Derivative
Assets(i)
Fair Value
Derivative
Liabilities(ii)
Fair Value
Derivative
Assets(i)
Fair Value
Derivative
Liabilities(ii)
Designated hedging instruments
Foreign currency forward contracts
$159 $351 $340 $44 
Non-designated hedging instruments
Foreign currency forward contracts
112 — 146 — 
Total fair value of hedging instruments
$271 $351 $486 $44 
_____________
(i)Included in prepaid expenses and other current assets on the condensed consolidated balance sheets.
(ii)Included in accrued liabilities and other liabilities on the condensed consolidated balance sheets.
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)
The before-tax effects of derivative instruments designated as cash flow hedges on the accumulated other comprehensive loss and condensed consolidated statements of operations for the periods indicated below are as follows (in thousands):
Three Months Ended September 30,Nine months ended September 30,
2024202320242023
Amount of (loss) gain recognized in other comprehensive income (loss)(i)
$(385)$(932)$148 $1,522 
Amount of gain (loss) related to foreign exchange forward contracts reclassified from accumulated other comprehensive income (loss) into income(ii)
$235 $(7)$636 $(1,511)
_____________
(i)The before-tax loss of $385 related to foreign exchange forward contracts was recognized in other comprehensive income (loss) during the three months ended September 30, 2024. The before-tax loss of $932 related to foreign exchange forward contracts was recognized in other comprehensive income (loss) during the three months ended September 30, 2023. The before-tax gain of $148 related to foreign exchange forward contracts was recognized in other comprehensive income (loss) during the nine months ended September 30, 2024. The before-tax gain of $1,522 related to foreign exchange forward contracts was recognized in other comprehensive income (loss) during the nine months ended September 30, 2023.

(ii)The before-tax gains of $53 and $182 were included in cost of service revenues and operating expenses, primarily research and development expense, respectively, on the condensed consolidated statements of operations for the three months ended September 30, 2024. The before-tax losses of $2 and $5 were included in cost of service revenues and operating expenses, primarily research and development expense, respectively, on the condensed consolidated statements of operations for the three months ended September 30, 2023. The before-tax gains of $147 and $489 were included in cost of service revenues and operating expenses, primarily research and development expense, respectively, on the condensed consolidated statements of operations for the nine months ended September 30, 2024. The before-tax losses of $297 and $1,214 were included in cost of service revenues and operating expenses, primarily research and development expense, respectively, on the condensed consolidated statements of operations for the nine months ended September 30, 2023.
Schedule of Derivative Instruments, Gain (Loss)
The before-tax loss recognized in other (expense) income, net for non-designated foreign currency forward contracts for the periods indicated below are as follows (in thousands):
Three Months Ended September 30,Nine months ended September 30,
2024202320242023
Loss recognized in other (expense) income, net
$(42)$(143)$(73)$(36)